	Potential to improve early detection of lung cancer through expansion of focused and opportunistic screening approaches: a scoping review focusing on potential expansion of screening risk factors and adoption of artificial intelligence models. Lung Cancer Manag Mok TSK, Finley C, Köksal D, Li MSC, Shum E, Velotta JB, Yang PC. PMID: 42864862 [PubMed]
	Targeting the Tumor Microenvironment Network to Overcome Immunotherapy Resistance in Non-Small Cell Lung Cancer: Mechanisms to Clinical Translation. Cancer Med Wang Z, Luo Z, Wang L, Tang J, Zhang Z, Fan X. PMID: 42864833 [PubMed - indexed for MEDLINE]
	Who participates in LDCT screening for the early detection of lung cancer after long-term occupational exposure to asbestos dust? Results of the analysis of administrative and medical routine data from the German Social Accident Insurance. BMC Pulm Med Oubaid N, Greiner F, Keller H, Horn MA, Preisser AM, Harth V. PMID: 42864641 [PubMed - indexed for MEDLINE]
	First-line treatment outcomes in HER2-altered advanced NSCLC: a real-world multi-center study comparing trastuzumab deruxtecan with conventional therapies and analysis by HER2/EGFR co-alteration status. BMC Cancer Liu C, Li T, Qin BY, Yu L, Ji C, Liu M, Wang A, Wang YL, Liu ZF, Zhang T, Hu Y. PMID: 42864628 [PubMed - indexed for MEDLINE]
	AI-derived 3D body composition predicts prognosis of chemoimmunotherapy in small cell lung cancer: a multicenter study. J Immunother Cancer Li Y, Guo Y, Peng S, Mo P, Cheng D, Wang Y, Yang Y, Ren Y, Liang P, Liang X, Wu X, Liu C, Zhou G, Lei Z, Yang L. PMID: 42864144 [PubMed - in process]
	Identifying interoceptive awareness profiles and potential intervention targets in patients with lung cancer undergoing chemotherapy. Eur J Oncol Nurs Zhang X, Chen X, Li J, Wu X, Wang T, Teng L. PMID: 42863303 [PubMed - as supplied by publisher]
	Machine learning for differentiating primary lung cancer from pulmonary metastases and non-small cell lung cancer histological subtype classification: a systematic review. Clin Radiol Zare O, Ostovari M, Mahmoudi T. PMID: 42863195 [PubMed - as supplied by publisher]
	ReViT-RF: A hybrid ResNet-50-Vision Transformer with a Radiomic Feature Fusion framework for lung tumor classification and TNM-based stage prediction using CT images. PLoS One DA S, B RN. PMID: 42862867 [PubMed - indexed for MEDLINE]
	Primary feasibility analysis of neoadjuvant chemotherapy with bevacizumab for resectable stage II/IIIA non-squamous non-small cell lung cancer: the NAVAL phase II study. Jpn J Clin Oncol Tsubokawa N, Tsutani Y, Miyata Y, Suzuki K, Takamochi K, Tanaka F, Ito H, Yamashita Y, Oda M, Mimae T, Okada M. PMID: 42862717 [PubMed - as supplied by publisher]
	CT-guided methylene blue staining to facilitate thoracoscopic resection of intermediate-to-deep pulmonary metastases in pediatric patients. Pediatr Surg Int Obed M, Wennemann L, Linderkamp C, Pauer N, Shin HO, Vogel-Claussen J, Dingemann J, Kiblawi R. PMID: 42862376 [PubMed - indexed for MEDLINE]
	Prognostic value of diabetes-related clinical indices in patients with non-small cell lung cancer and comorbid type 2 diabetes receiving immune checkpoint inhibitor therapy. Acta Diabetol Ren Q, Zhang H, Huang D, Zhong H, Wu J, Wang Y, Zhao Y, Luo S, Li Y. PMID: 42862337 [PubMed - as supplied by publisher]
	Comparative toxicity and efficacy of consolidative thoracic radiotherapy after first-line chemoimmunotherapy in extensive-stage small-cell lung cancer: real-world retrospective cohort study. Strahlenther Onkol Bai B, Jiang Y, Meng H, Song L, Wu K, Wei J, Si N. PMID: 42862283 [PubMed - as supplied by publisher]
	Association between overall dietary antioxidant capacity and lung cancer risk: findings from two observational studies. Eur J Epidemiol Sun T, Zhang L, Luo X, Wang L, Xue Q, Song W, Li W, Tu H, Wu X. PMID: 42862260 [PubMed - as supplied by publisher]
	Antibody-drug conjugates in lung cancer: clinical development, therapeutic advances, and emerging challenges. Cancer Chemother Pharmacol Zhao Y, Ma X, Liu X, Yan L. PMID: 42862216 [PubMed - indexed for MEDLINE]
	Systematic review of spectral computed tomography quantitative parameters for predicting EGFR mutation status in non-small cell lung cancer. Quant Imaging Med Surg Li J, Gao L, Jiao X, Xia F, Jia N, Huang Y, Wang S, Sun S, Huang S. PMID: 42861248 [PubMed]
	A study to learn how well HER3-DXd (patritumab deruxtecan) works and how safe it is in people with previously treated non-small-cell lung cancer that has a mutation in the EGFR gene: a plain language summary of the HERTHENA-Lung01 study. Future Oncol Yu HA, Goto Y, Jänne PA. PMID: 42860885 [PubMed - as supplied by publisher]
	Lymph node yield and station count in early robot-assisted versus established video-assisted resection for non-small cell lung cancer: higher total node counts reflect yield per sampled station. J Robot Surg Kim JD, Lee YS, Yang JW. PMID: 42860470 [PubMed - indexed for MEDLINE]
	Metastatic Lung Adenocarcinoma to the Uterus Mimicking a Primary Uterine Malignancy: A Case Report. Cancer Rep (Hoboken) Sun P, Wang Y. PMID: 42860291 [PubMed - indexed for MEDLINE]
	Comparative Evaluation of Concurrent Carboplatin-Paclitaxel Versus Cisplatin-Etoposide Chemoradiotherapy in Unresectable Non-small Cell Lung Cancer: A Prospective Randomized Study. Cureus Kumar Y, Subramanian BV, Deepthi GV, Das P, Bonala SR. PMID: 42859818 [PubMed]
	AI-Assisted Volumetric Comparison of Parenchyma-Sparing Effect in Robotic Segmentectomy vs Lobectomy. JSLS Sayan M, Aytekin Celik I, Fattahov M, Artiran B, Temirkaynak FO, Celik A. PMID: 42859444 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 162661

Page 1 of 8134



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy